Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
JQu8T9CeGZELEzBL
